A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples